Connect with us

Published

on

Elon Musk said on Wednesday a wireless device developed by his brain chip company Neuralink is expected to begin human clinical trials in six months.

The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again. Based in the San Francisco Bay Area and Austin, Texas, Neuralink has in recent years been conducting tests on animals as it seeks US regulatory approval to begin clinical trials in people.

“We want to be extremely careful and certain that it will work well before putting a device into a human but we’ve submitted I think most of our paperwork to the FDA and probably in about six months we should be able to upload Neuralink in a human,” Musk said during a much-awaited public update on the device.

The event was originally planned for October 31 but Musk postponed it just days before without giving a reason.

Neuralink’s last public presentation, more than a year ago, involved a monkey with a brain chip that played a computer game by thinking alone.

Musk is known for lofty goals such as colonizing Mars and saving humanity. His ambitions for Neuralink, which he launched in 2016, are of the same grand scale. He wants to develop a chip that would allow the brain to control complex electronic devices and eventually allow people with paralysis to regain motor function and treat brain diseases such as Parkinson’s, dementia and Alzheimer’s. He also talks about melding the brain with artificial intelligence.

Neuralink, however, is running behind schedule. Musk said in a 2019 presentation he was aiming to receive regulatory approval by the end of 2020. He then said at a conference in late 2021 that he hoped to start human trials this year.

Neuralink has repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials, current and former employees have said. Musk approached competitor Synchron earlier this year about a potential investment after he expressed frustration to Neuralink employees about their slow progress, Reuters reported in August.

Synchron crossed a major milestone in July by implanting its device in a patient in the United States for the first time. It received US regulatory clearance for human trials in 2021 and has completed studies in four people in Australia.

© Thomson Reuters 2022


Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Science

Watch Neuralink’s First Brain-Chip Patient Playing Chess Using His Mind

Published

on

By

Watch Neuralink's First Brain-Chip Patient Playing Chess Using His Mind

Elon Musk’s brain-chip startup Neuralink livestreamed on Wednesday its first patient implanted with a chip using his mind to play online chess.

Noland Arbaugh, the 29-year-old patient who was paralyzed below the shoulder after a diving accident, played chess on his laptop and moved the cursor using the Neuralink device. The implant seeks to enable people to control a computer cursor or keyboard using only their thoughts.

Arbaugh had received an implant from the company in January and could control a computer mouse using his thoughts, Musk said last month.

“The surgery was super easy,” Arbaugh said in the video streamed on Musk’s social media platform X, referring to the implant procedure. “I literally was released from the hospital a day later. I have no cognitive impairments.

“I had basically given up playing that game,” Arbaugh said, referring to the game Civilization VI, “you all (Neuralink) gave me the ability to do that again and played for 8 hours straight.”

Elaborating on his experience with the new technology, Arbaugh said that it is “not perfect” and they “have run into some issues.”

“I don’t want people to think that this is the end of the journey, there’s still a lot of work to be done, but it has already changed my life,” he added.

Kip Ludwig, former program director for neural engineering at the U.S. National Institutes of Health, said what Neuralink showed was not a “breakthrough.”

“It is still in the very early days post-implantation, and there is a lot of learning on both the Neuralink side and the subject’s side to maximize the amount of information for control that can be achieved,” he added.

Even so, Ludwig said it was a positive development for the patient that they have been able to interface with a computer in a way they were not able to before the implant. “It’s certainly a good starting point,” he said.

Last month, Reuters reported that the U.S. Food and Drug Administration inspectors found problems with record keeping and quality controls for animal experiments at Elon Musk’s Neuralink, less than a month after the startup said it was cleared to test its brain implants in humans. Neuralink did not respond then to questions about the FDA’s inspection.

© Thomson Reuters 2024


(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Science

Government Eases Approval Process for FDI in Space Sector

Published

on

By

Government Eases Approval Process for FDI in Space Sector

India will allow 100% foreign direct investment in the manufacture of satellite systems without official approval and eased the rules for launch vehicles, a government statement said, aiming for a greater share of the global space market.

India’s space ambitions got a boost when it became the first country to land a spacecraft near the unexplored south pole of the moon in August – and the fourth to achieve a soft landing – just days after a similar Russian mission failed.

The government said in a statement late on Wednesday that foreign companies could invest in the manufacture of components and systems or sub-systems for satellites up to 100% without approval.

Foreign firms planning to build satellites in India would not require government approval up to 74% of the investment; for investment in launch vehicles, investment could go up to 49% without such approval, the statement said.

India has privatised space launches and is aiming for a five-fold increase in its share of the global launch market, which some expect to be worth $47.3 billion by 2032. India currently accounts for about 2% of the space economy.

The country hopes that liberalised rules for the space sector, long controlled by the government, will draw interest from Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin, among others.

The foreign direct investment policy reform is expected to boost employment and will allow companies to set up manufacturing facilities in India, the government said in the statement.

“This will give India access to the latest tech advances and much-needed funds, not only from the country but from international investors too,” said A.K. Bhatt, director general of the Indian Space Association.

Space-related India stocks such as Paras Defence and Space Technologies , MTAR Technologies, Taneja Aerospace and Aviation and Apollo Micro Systems climbed 2% to 5% on Thursday.

© Thomson Reuters 2024


(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Science

Neuralink Switches Location From Delaware to Nevada

Published

on

By

Neuralink Switches Location From Delaware to Nevada

Elon Musk‘s brain-chip implant company, Neuralink, changed its location of incorporation from Delaware to Nevada, according to the business portals of both states.

The development comes about a week after Musk said Tesla would hold a shareholder vote to transfer its state of incorporation to Texas from Delaware after a judge invalidated his $56 billion (roughly Rs. 4,64,880 crore) pay package.

However, switching the state of incorporation for Tesla could come with hurdles such as investor lawsuits, particularly if it was seen as a move to secure his pay package, legal experts said.

Musk said last week that Neuralink had implanted its first brain chip in a human patient, who was recovering well after the procedure.

Neuralink did not immediately respond to a Reuters request for comment.

In September 2023, the company received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.

Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.

The study will use a robot to surgically place a brain-computer interface (BCI) implant in a region of the brain that controls the intention to move, Neuralink said, adding that its initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.

© Thomson Reuters 2024


Is the iQoo Neo 7 Pro the best smartphone you can buy under Rs. 40,000 in India? We discuss the company’s recently launched handset and what it has to offer on the latest episode of Orbital, the Gadgets 360 podcast. Orbital is available on Spotify, Gaana, JioSaavn, Google Podcasts, Apple Podcasts, Amazon Music and wherever you get your podcasts.
Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Trending